Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Context Therapeutics Inc. | 123,500 | reported | 12 Jun 2025 | tx 4+198,500 |
| Galera Therapeutics, Inc. | 23,382 | reported | 01 Jul 2023 | tx 12+243,272 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Jun 2025 | GRANT_AWARD | Context Therapeutics Inc. | 123,500 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | Context Therapeutics Inc. | 25,000 | 0.00 USD | deriv |
| 01 Jul 2023 | GRANT_AWARD | Galera Therapeutics, Inc. | 23,382 | 0.00 USD | deriv |
| 14 Jun 2023 | GRANT_AWARD | Galera Therapeutics, Inc. | 48,000 | 0.00 USD | deriv |
| 31 May 2023 | GRANT_AWARD | Context Therapeutics Inc. | 25,000 | 0.00 USD | deriv |
| 01 Jul 2022 | GRANT_AWARD | Galera Therapeutics, Inc. | 58,496 | 0.00 USD | deriv |
| 15 Jun 2022 | GRANT_AWARD | Galera Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 02 Jun 2022 | GRANT_AWARD | Context Therapeutics Inc. | 25,000 | 0.00 USD | deriv |
| 17 Dec 2021 | PURCHASE | Galera Therapeutics, Inc. | 20,000 | 2.74 USD | |
| 01 Jul 2021 | GRANT_AWARD | Galera Therapeutics, Inc. | 8,730 | 0.00 USD | deriv |
| 15 Jun 2021 | PURCHASE | Galera Therapeutics, Inc. | 10,000 | 9.13 USD | |
| 16 Jun 2021 | GRANT_AWARD | Galera Therapeutics, Inc. | 9,888 | 0.00 USD | deriv |
| 02 Jun 2021 | PURCHASE | Galera Therapeutics, Inc. | 10,000 | 8.65 USD | |
| 01 Jun 2021 | PURCHASE | Galera Therapeutics, Inc. | 10,000 | 8.64 USD | |
| 28 May 2021 | PURCHASE | Galera Therapeutics, Inc. | 10,000 | 8.64 USD | |
| 31 Mar 2020 | GRANT_AWARD | Galera Therapeutics, Inc. | 19,776 | 0.00 USD | deriv |